F 0658
Ensure services provided by the nursing facility meet professional standards of quality.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
interview and record review the facility failed to ensure services met professional standards for one resident
(Resident 1) of two sampled residents when:
Residents Affected - Few
1. The physician ordered sodium polystyrene sulfonate (SPS, a medication used to treat high levels of
potassium) to treat Resident 1's high ammonia level;
2. The Licensed Nurse 1 (LN 1) obtained a telephone order from the physician and did not include the
prescriber's name, the time the medication should be given, and the indication for the medication; and,
3. The LN 1 administered the medication without knowledge of what it was for.
This failure decreased the facility's potential to administer medications safely to residents.
Findings:
1. A review of a face sheet indicated Resident 1 was admitted to the facility on [DATE] with diagnoses
including a kidney cyst (a pouch of fluid on the kidney). A review of a Minimum Data Set (MDS, an
assessment tool), dated 3/31/23, indicated Resident 1 had moderate memory problems.
A review of Resident 1's clinical record indicated the following:
· A lab result. dated 3/27/23, indicated a high ammonia level of 42 mcmol/L (micromoles per liter, a
unit of measure); a normal range for ammonia was between 9- 35 mcmol/L.
· A medication administration record (MAR), dated March 2023, indicated Resident 1 was
administered the SPS on 3/28/23.
· A lab result, dated 4/3/23, indicated a higher ammonia level of 58 mcmol/L.
· An MAR dated April 2023 indicated Resident 1 was administered the SPS on 4/4/23 and 4/5/23.
In an interview on 4/20/23 at 2:40 p.m., the Physician stated he mistakenly ordered the SPS for Resident 1.
The Physician confirmed the SPS lowered potassium, not ammonia, and stated Resident 1 should not have
been given it.
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 3
Event ID:
055173
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055173
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
04/19/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Folsom Care Center
510 Mill Street
Folsom, CA 95630
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0658
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
2. A review of Resident 1's written physician's order dated 3/28/23 at indicated, Give [SPS] 30 gm (gm:
grams, a unit of measurement) PO [orally] +1 . The order did not indicate the time the medication was to be
given, it did not clearly indicate the frequency it was to be given, nor did it indicate the reason the
medication was to be given.
A review of Resident 1's written physician's orders, dated 4/4/23 indicated, Give [SPS] 30 gm orally once a
day for two days (2 doses). The order did not indicate it was received via the telephone, the name of the
licensed staff who received the order, the physician's name, the time the medication was to be given, or the
reason the medication was ordered.
A review of Resident 1's MAR dated March 2023 and April 2023 did not indicate the reason the SPS was to
be given.
In an interview on 4/20/23 at 2:15 p.m., the LN 1 confirmed she received a telephone order from the
Physician who ordered SPS 30 gm by mouth for two days. The LN 1 verified she had not clarified the order
with the Physician.
In an interview on 4/21/23 at 3 p.m., the Director of Nurses (DON) confirmed the LN 1 did not indicate the
prescriber's name, the time the medication should be given, and the indication of the SPS on Resident 1's
chart. The DON also stated it was expected of a licensed nurse to include the following information when an
order is received over the telephone: the name of the drug, the indication for the drug, the frequency it
should be given, the dose to be given, the prescriber's name, and the licensed nurse's name who received
the order.
3. A review of Resident 1's clinical record indicated the following:
· A lab result dated 3/27/23 indicated a normal potassium level of 4.1 mmol/L (millimoles per liter, a
unit of measure); a normal range for potassium was between 3.6- 5.1 mmol/L.
· A lab result dated 4/3/23 indicated a normal potassium level of 4 mmol/L.
· A lab result, dated 4/6/23, indicated a low potassium level of 3.2 mmol/L.
· A physician's order dated 4/7/23 for potassium chloride extended release meq (milliequivalent, a
unit of measure) table; give one table oral once a day every day for three days.
A review of the Food & Drug Administration's informational data on SPS, revised December 2010,
indicated, [SPS] is indicated for the treatment of hyperkalemia [high potassium level] .Serious potassium
deficiency can occur from therapy with [SPS] .Early clinical signs of severe hypokalemia include a pattern
of irritable confusion and delayed though processes .
In an interview on 4/20/23 at 2:15 p.m., LN 1 stated she presumed Resident 1's order for SPS was correct
since it came directly from the physician. The LN 1 was unable to state the indication for SPS in Resident
1's case.
In an interview on 4/21/23 at 3 p.m., the DON stated the nurse giving a medication must know the
indication for giving it so if the order has an error, it could be clarified with the prescriber.
A review of the facility's policy titled Medication Orders, dated March 2018, indicated, Any dose
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
055173
If continuation sheet
Page 2 of 3
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055173
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
04/19/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Folsom Care Center
510 Mill Street
Folsom, CA 95630
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0658
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
or order that appears inappropriate considering the resident's .condition .or diagnosis is verified with the
attending physician .Each medication is documented in the resident's medical record with the date and
signature of the person receiving the order .is recorded on the physician's order sheet or the telephone
order sheet if it is a verbal order, and on the MAR .All drug orders shall be written, dated .The name,
quantity or specific duration of therapy, dosage and time or frequency of administration of the drug, and the
route of administration if other than oral shall be specific .
Event ID:
Facility ID:
055173
If continuation sheet
Page 3 of 3